Citigroup Global Markets Participates in Financing Facility for Pure DC

'A Group Of Financial Firms Including Goldman Sachs Group, Citigroup, Banco Santander SA And Deutsche Bank AG Have Committed Around $270M In Funding Toward A Joint Stablecoin Venture' - Bloomberg Law

Citigroup Inc. Announces Redemption of Series Y Preferred Stock

Citigroup Inc. has announced the full redemption of its 4.150% Fixed Rate Reset Noncumulative Preferred Stock, Series Y, totaling $1.0 billion in aggregate liquidation preference.

Citigroup Raises Price Target on PTC Therapeutics

Citigroup maintained its Buy rating on PTC Therapeutics, Inc. (NASDAQ: PTCT) and increased its price target for the company's stock.

Citi Participates in Launch of Canada's Real-Time Rail Payment System

Citi Canada is participating in the newly launched Real-Time Rail (RTR) payment infrastructure in Canada, which enables instant payment settlement.

Citi Downgrades Global Tech Stocks to Neutral

Citi's global strategy team has downgraded U.S., global, and European technology stocks to neutral, citing market turbulence and a shift in leadership toward defensive sectors.

Nebius Stock: The Bull Case, the Bear Case, and My Call Before Nov. 12

Nebius Group stock has fallen 47% from its June peak to around $152. The bull case rests on management's target of $7-9 billion annualized run-rate revenue by year-end 2026 (up from $3 billion in June), with the company demonstrating strong growth momentum. However, the bear case highlights massive capital expenditure needs ($20-25 billion in 2026) requiring significant external funding, customer concentration risk (3 customers = 59% of revenue), and reliance on share dilution and debt. The analyst recommends waiting for Q3 results on Nov. 12 to assess if the company remains on track for its targets before making an investment decision.